WASHINGTON (March 18, 2013)—The U.S. Food and Drug Administration is warning doctors and hospital managers about a nationwide recall of all drugs made by a New Jersey compounding pharmacy because of possible mold contamination.
The recalled products from Med Prep Consulting Inc. include dozens of drugs packaged in infusion bags, plastic syringes and glass vials that were distributed to regional hospitals.
Mold was found in five bags of magnesium sulfate products dispensed to a Connecticut hospital, the Tinton Falls, N.J.-based company said on Saturday.
No infections have been reported to date, but the FDA said it is working with officials in New Jersey and Connecticut to determine the scope of the contamination.
A tainted steroid distributed by an unrelated pharmacy last year has killed 50 people and sickened more than 720 nationwide.